Filed: 2/17/2026ACC: 0001072613-26-000191
📋 What this filing means
NEA MANAGEMENT COMPANY, LLC filed this quarterly 13F‑HR report disclosing 27 equity positions with a total reported market value of $1.96B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
27
Positions
$1.96B
Total AUM (reported)
130.94M
Total Shares
Allocation by class
COM$1.68B85.5%
COMMON STOCK$198.55M10.1%
NAMEN AKT$55.51M2.8%
COM NEW$21.46M1.1%
ADS$6.80M0.3%
COM CL A$1.39M0.1%
Portfolio Concentration
Top 3$862.67M44.0%
4–10$833.67M42.5%
11–25$263.06M13.4%
Rest$1.73M0.1%
Top 3 weight
44.0%
Top 10 weight
86.5%
Voting Authority Distribution
Total shares with voting rights: 130.94M
Sole
Full voting authority
130.94M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other27
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings27
Rows:
Celcuity Inc.
DFNDShares3.54M
TypeSH
Market value$352.64M
17.98%
Sole
3.54M
Shared
0.00
None
0.00
Rhythm Pharmaceuticals, Inc.
DFNDShares2.91M
TypeSH
Market value$311.48M
15.88%
Sole
2.91M
Shared
0.00
None
0.00
Arcellx, Inc.
DFNDShares3.05M
TypeSH
Market value$198.55M
10.12%
Sole
3.05M
Shared
0.00
None
0.00
Trevi Therapeutics, Inc.
DFNDShares13.22M
TypeSH
Market value$165.54M
8.44%
Sole
13.22M
Shared
0.00
None
0.00
Savara, Inc.
DFNDShares24.47M
TypeSH
Market value$147.56M
7.52%
Sole
24.47M
Shared
0.00
None
0.00
Zenas BioPharma, Inc.
DFNDShares3.52M
TypeSH
Market value$127.93M
6.52%
Sole
3.52M
Shared
0.00
None
0.00
Monte Rosa Therapeutics, Inc.
DFNDShares7.69M
TypeSH
Market value$120.62M
6.15%
Sole
7.69M
Shared
0.00
None
0.00
MBX Biosciences, Inc.
DFNDShares3.61M
TypeSH
Market value$114.00M
5.81%
Sole
3.61M
Shared
0.00
None
0.00
Coursera, Inc.
DFNDShares12.87M
TypeSH
Market value$94.71M
4.83%
Sole
12.87M
Shared
0.00
None
0.00
Aurinia Pharmaceuticals, Inc.
DFNDShares3.97M
TypeSH
Market value$63.32M
3.23%
Sole
3.97M
Shared
0.00
None
0.00
Gossamer Bio, Inc.
DFNDShares18.09M
TypeSH
Market value$56.09M
2.86%
Sole
18.09M
Shared
0.00
None
0.00
CRISPR Therapeutics AG
DFNDShares1.06M
TypeSH
Market value$55.51M
2.83%
Sole
1.06M
Shared
0.00
None
0.00
ORIC Pharmaceuticals, Inc.
DFNDShares4.12M
TypeSH
Market value$33.69M
1.72%
Sole
4.12M
Shared
0.00
None
0.00
Phathom Pharmaceauticals, Inc.
DFNDShares1.96M
TypeSH
Market value$32.52M
1.66%
Sole
1.96M
Shared
0.00
None
0.00
CVRx, Inc.
DFNDShares2.03M
TypeSH
Market value$14.39M
0.73%
Sole
2.03M
Shared
0.00
None
0.00
X4 Pharmaceuticals, Inc.
DFNDShares3.23M
TypeSH
Market value$12.93M
0.66%
Sole
3.23M
Shared
0.00
None
0.00
Champions Oncology, Inc.
DFNDShares1.71M
TypeSH
Market value$11.84M
0.60%
Sole
1.71M
Shared
0.00
None
0.00
Black Diamond Therapeutics, Inc.
DFNDShares4.45M
TypeSH
Market value$10.81M
0.55%
Sole
4.45M
Shared
0.00
None
0.00
Korro Bio, Inc.
DFNDShares1.09M
TypeSH
Market value$8.74M
0.45%
Sole
1.09M
Shared
0.00
None
0.00
Inventiva SA
DFNDShares1.46M
TypeSH
Market value$6.80M
0.35%
Sole
1.46M
Shared
0.00
None
0.00
Nkarta, Inc.
DFNDShares3.57M
TypeSH
Market value$6.60M
0.34%
Sole
3.57M
Shared
0.00
None
0.00
Senti Biosciences, Inc.
DFNDShares3.78M
TypeSH
Market value$3.93M
0.20%
Sole
3.78M
Shared
0.00
None
0.00
LeonaBio, Inc.
DFNDShares464.40K
TypeSH
Market value$3.52M
0.18%
Sole
464.40K
Shared
0.00
None
0.00
Synlogic, Inc.
DFNDShares2.92M
TypeSH
Market value$3.27M
0.17%
Sole
2.92M
Shared
0.00
None
0.00
Marker Therapeutics, Inc.
DFNDShares1.63M
TypeSH
Market value$2.42M
0.12%
Sole
1.63M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Celcuity Inc.DFND | COM | 3.54M | SH | $352.64M 17.98% | 3.54M | 0.00 | 0.00 |
Rhythm Pharmaceuticals, Inc.DFND | COM | 2.91M | SH | $311.48M 15.88% | 2.91M | 0.00 | 0.00 |
Arcellx, Inc.DFND | COMMON STOCK | 3.05M | SH | $198.55M 10.12% | 3.05M | 0.00 | 0.00 |
Trevi Therapeutics, Inc.DFND | COM | 13.22M | SH | $165.54M 8.44% | 13.22M | 0.00 | 0.00 |
Savara, Inc.DFND | COM | 24.47M | SH | $147.56M 7.52% | 24.47M | 0.00 | 0.00 |
Zenas BioPharma, Inc.DFND | COM | 3.52M | SH | $127.93M 6.52% | 3.52M | 0.00 | 0.00 |
Monte Rosa Therapeutics, Inc.DFND | COM | 7.69M | SH | $120.62M 6.15% | 7.69M | 0.00 | 0.00 |
MBX Biosciences, Inc.DFND | COM | 3.61M | SH | $114.00M 5.81% | 3.61M | 0.00 | 0.00 |
Coursera, Inc.DFND | COM | 12.87M | SH | $94.71M 4.83% | 12.87M | 0.00 | 0.00 |
Aurinia Pharmaceuticals, Inc.DFND | COM | 3.97M | SH | $63.32M 3.23% | 3.97M | 0.00 | 0.00 |
Gossamer Bio, Inc.DFND | COM | 18.09M | SH | $56.09M 2.86% | 18.09M | 0.00 | 0.00 |
CRISPR Therapeutics AGDFND | NAMEN AKT | 1.06M | SH | $55.51M 2.83% | 1.06M | 0.00 | 0.00 |
ORIC Pharmaceuticals, Inc.DFND | COM | 4.12M | SH | $33.69M 1.72% | 4.12M | 0.00 | 0.00 |
Phathom Pharmaceauticals, Inc.DFND | COM | 1.96M | SH | $32.52M 1.66% | 1.96M | 0.00 | 0.00 |
CVRx, Inc.DFND | COM | 2.03M | SH | $14.39M 0.73% | 2.03M | 0.00 | 0.00 |
X4 Pharmaceuticals, Inc.DFND | COM | 3.23M | SH | $12.93M 0.66% | 3.23M | 0.00 | 0.00 |
Champions Oncology, Inc.DFND | COM NEW | 1.71M | SH | $11.84M 0.60% | 1.71M | 0.00 | 0.00 |
Black Diamond Therapeutics, Inc.DFND | COM | 4.45M | SH | $10.81M 0.55% | 4.45M | 0.00 | 0.00 |
Korro Bio, Inc.DFND | COM | 1.09M | SH | $8.74M 0.45% | 1.09M | 0.00 | 0.00 |
Inventiva SADFND | ADS | 1.46M | SH | $6.80M 0.35% | 1.46M | 0.00 | 0.00 |
Nkarta, Inc.DFND | COM | 3.57M | SH | $6.60M 0.34% | 3.57M | 0.00 | 0.00 |
Senti Biosciences, Inc.DFND | COM NEW | 3.78M | SH | $3.93M 0.20% | 3.78M | 0.00 | 0.00 |
LeonaBio, Inc.DFND | COM | 464.40K | SH | $3.52M 0.18% | 464.40K | 0.00 | 0.00 |
Synlogic, Inc.DFND | COM NEW | 2.92M | SH | $3.27M 0.17% | 2.92M | 0.00 | 0.00 |
Marker Therapeutics, Inc.DFND | COM NEW | 1.63M | SH | $2.42M 0.12% | 1.63M | 0.00 | 0.00 |
Page 1 of 2